RxDoctor Payments Data

Keith Kyker, MD

Clinical Cardiac Electrophysiology · Powell, TNNPI 1437245636

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.4% of the total across 402 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Abbott at 25.9% of the total. 2025 is the largest year on record at $1,997, 2.0 times the $985 reported in 2019. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in TN, where the typical reported total is $12,690.

$8,917in general payments, 2019–2025

Across 402 payments — averaging $22.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Boston Scientific$1K
  • Medtronic$1K
  • Atricure, Inc.$952
  • Novartis$799
  • Biosense Webster, Inc.$754
  • plus $2K from 19 others

What the payments were for

  • Travel & lodging$3434%
  • Food & beverage$8,50495%
  • Education$701%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,917 in reported general payments places this provider in the 45th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.

See all clinical cardiac electrophysiology providers in Tennessee

Medicare billing

Part B allowed, 2024
$71,356
Medicare patients
163
Services billed
454

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban94$83,395
Dofetilide14$5,983
Flecainide Acetate21$1,120
Amiodarone Hcl19$448
Diltiazem 24hr Er (Cd)Diltiazem Hcl30$352
Metoprolol Succinate38$212
Warfarin Sodium13$146
Metoprolol Tartrate34$136
Amlodipine Besylate19$133
Carvedilol16$91
Lisinopril11$35

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$130$83,39594 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.

Other clinical cardiac electrophysiology in Powell

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →